Etanercept injectable solution is available as brand-name drugs. It’s not available as a generic drug. Brand names: Enbrel, Erelzi. Etanercept comes only in the form of an injectable solution. It ...

If you have certain types of arthritis or plaque psoriasis, your doctor may prescribe Enbrel. It’s used to treat the following conditions: Enbrel contains the active drug etanercept, which is a ...

Enbrel (etanercept) is a prescription brand-name medication. It’s approved by the Food and Drug Administration (FDA) to treat the following conditions: For each of these conditions, Enbrel is ...

People with rheumatoid arthritis often take medicines to help manage their condition and improve their symptoms. Some of these medicines work directly on the body’s immune system and help to limit the ...

Please provide your email address to receive an email when new articles are posted on . Approximately 70% of patients with juvenile idiopathic arthritis who are re-treated with etanercept achieve ...

Please provide your email address to receive an email when new articles are posted on . To determine the efficacy of monotherapy with either methotrexate or etanercept (Enbrel, Amgen), as well as ...

Amgen (NASDAQ:AMGN) today issued the following statement: Amgen today announced the issuance of U.S. Patent No. 8,063,182 related to Enbrel® (etanercept). This patent is owned by Hoffman-La Roche Inc.

San Antonio, TX - Etanercept (Enbrel, Wyeth) is no better than placebo at inducing or maintaining remission in Wegener's granulomatosis (WG) and may increase risk of solid malignancy, according to ...

Rhodes, Greece, 5 October 2006 -- There was good news for psoriasis patients today as the latest study confirming the established safety profile of ENBREL® (etanercept) for up to 2.5 years , was ...

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved ETICOVO™ (etanercept-ykro), a biosimilar referencing ENBREL ® ...

THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...